{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:50:53Z","timestamp":1783713053393,"version":"3.55.0"},"publisher-location":"Cham","reference-count":224,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030462260","type":"print"},{"value":"9783030462277","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-46227-7_9","type":"book-chapter","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T19:02:50Z","timestamp":1599850970000},"page":"171-191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Molecular Biology of Basal and Squamous Cell Carcinomas"],"prefix":"10.1007","author":[{"given":"Lars","family":"Boeckmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Christine","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Emmert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,12]]},"reference":[{"issue":"4","key":"9_CR1","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1158\/0008-5472.CAN-05-2146","volume":"66","author":"C Adolphe","year":"2006","unstructured":"Adolphe C, Hetherington R, Ellis T, et al. Patched1 functions as a gatekeeper by promoting cell cycle progression. Cancer Res. 2006;66(4):2081\u20138.","journal-title":"Cancer Res"},{"issue":"1","key":"9_CR2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/1097-0142(19910701)68:1<195::AID-CNCR2820680135>3.0.CO;2-L","volume":"68","author":"M Aho","year":"1991","unstructured":"Aho M, Vesterinen E, Meyer B, et al. Natural history of vaginal intraepithelial neoplasia. Cancer. 1991;68(1):195\u20137.","journal-title":"Cancer"},{"key":"9_CR3","unstructured":"American Cancer Society. Cancer Facts & Figures. 2019:2019."},{"issue":"6","key":"9_CR4","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1046\/j.1523-1747.1998.00222.x","volume":"110","author":"M Aszterbaum","year":"1998","unstructured":"Aszterbaum M, Rothman A, Johnson RL, et al. Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol. 1998;110(6):885\u20138.","journal-title":"J Invest Dermatol"},{"issue":"9","key":"9_CR5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1600-0625.2006.00473.x","volume":"15","author":"M Athar","year":"2006","unstructured":"Athar M, Tang X, Lee JL, et al. Hedgehog signalling in skin development and cancer. Exp Dermatol. 2006;15(9):667\u201377.","journal-title":"Exp Dermatol"},{"issue":"3","key":"9_CR6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ccell.2015.02.002","volume":"27","author":"SX Atwood","year":"2015","unstructured":"Atwood SX, Sarin KY, Whitson RJ, et al. Smoothened variants explain the majority of drug resistance in basal cell carcinoma. Cancer Cell. 2015;27(3):342\u201353.","journal-title":"Cancer Cell"},{"issue":"6","key":"9_CR7","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1046\/j.1365-2559.2002.01393.x","volume":"40","author":"S Auepemkiate","year":"2002","unstructured":"Auepemkiate S, Boonyaphiphat P, Thongsuksai P. p53 expression related to the aggressive infiltrative histopathological feature of basal cell carcinoma. Histopathology. 2002;40(6):568\u201373.","journal-title":"Histopathology"},{"issue":"1\u20132","key":"9_CR8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mrfmmm.2004.10.011","volume":"571","author":"H Backvall","year":"2005","unstructured":"Backvall H, Asplund A, Gustafsson A, et al. Genetic tumor archeology: microdissection and genetic heterogeneity in squamous and basal cell carcinoma. Mutat Res. 2005;571(1\u20132):65\u201379.","journal-title":"Mutat Res"},{"issue":"2","key":"9_CR9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bjc.6601894","volume":"91","author":"S Bamford","year":"2004","unstructured":"Bamford S, Dawson E, Forbes S, et al. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer. 2004;91(2):355\u20138.","journal-title":"Br J Cancer"},{"issue":"8630","key":"9_CR10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(89)91143-4","volume":"1","author":"BB Barr","year":"1989","unstructured":"Barr BB, Benton EC, McLaren K, et al. Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet. 1989;1(8630):124\u20139.","journal-title":"Lancet"},{"issue":"1","key":"9_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2002.125579","volume":"47","author":"D Berg","year":"2002","unstructured":"Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol. 2002;47(1):1\u201317.. quiz 18-20","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"9_CR12","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/carcin\/bgi055","volume":"26","author":"S Blankenburg","year":"2005","unstructured":"Blankenburg S, Konig IR, Moessner R, et al. Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study. Carcinogenesis. 2005;26(6):1085\u201390.","journal-title":"Carcinogenesis"},{"issue":"5","key":"9_CR13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1523-1747.2001.01315.x","volume":"116","author":"JM Bonifas","year":"2001","unstructured":"Bonifas JM, Pennypacker S, Chuang PT, et al. Activation of expression of hedgehog target genes in basal cell carcinomas. J Invest Dermatol. 2001;116(5):739\u201342.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"9_CR14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng.3525","volume":"48","author":"X Bonilla","year":"2016","unstructured":"Bonilla X, Parmentier L, King B, et al. Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma. Nat Genet. 2016;48(4):398\u2013406.","journal-title":"Nat Genet"},{"key":"9_CR15","unstructured":"Bootsma D, Kraemer K H, Cleaver J E et al. Nucleotide excision repair syndromes: Xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. In: The Genetic Basis of Human Cancer, pp. 211\u2013237."},{"issue":"6","key":"9_CR16","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/bjd.14642","volume":"175","author":"L Borradori","year":"2016","unstructured":"Borradori L, Sutton B, Shayesteh P, et al. Rescue therapy with anti-programmed cell death protein 1 inhibitors of advanced cutaneous squamous cell carcinoma and basosquamous carcinoma: preliminary experience in five cases. Br J Dermatol. 2016;175(6):1382\u20136.","journal-title":"Br J Dermatol"},{"issue":"10","key":"9_CR17","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/carcin\/bgi123","volume":"26","author":"P Boukamp","year":"2005","unstructured":"Boukamp P. Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis. 2005;26(10):1657\u201367.","journal-title":"Carcinogenesis"},{"issue":"5","key":"9_CR18","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1067\/mjd.2002.120467","volume":"46","author":"AS Boyd","year":"2002","unstructured":"Boyd AS, Shyr Y, King LE. Basal cell carcinoma in young women: an evaluation of the association of tanning bed use and smoking. J Am Acad Dermatol. 2002;46(5):706\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"9_CR19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/jmg.2010.083022","volume":"48","author":"PT Bradford","year":"2011","unstructured":"Bradford PT, Goldstein AM, Tamura D, et al. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet. 2011;48(3):168\u201376.","journal-title":"J Med Genet"},{"issue":"22","key":"9_CR20","doi-asserted-by":"crossref","first-page":"10124","DOI":"10.1073\/pnas.88.22.10124","volume":"88","author":"DE Brash","year":"1991","unstructured":"Brash DE, Rudolph JA, Simon JA, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA. 1991;88(22):10124\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"9_CR21","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.0022-202X.2004.22501.x","volume":"122","author":"VL Brown","year":"2004","unstructured":"Brown VL, Harwood CA, Crook T, et al. p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma. J Invest Dermatol. 2004;122(5):1284\u201392.","journal-title":"J Invest Dermatol"},{"issue":"51","key":"9_CR22","doi-asserted-by":"crossref","first-page":"51ra70","DOI":"10.1126\/scitranslmed.3001599","volume":"2","author":"S Buonamici","year":"2010","unstructured":"Buonamici S, Williams J, Morrissey M, et al. Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma. Sci Transl Med. 2010;2(51):51ra70.","journal-title":"Sci Transl Med"},{"key":"9_CR23","doi-asserted-by":"crossref","first-page":"12493","DOI":"10.1038\/ncomms12493","volume":"7","author":"P Cammareri","year":"2016","unstructured":"Cammareri P, Rose AM, Vincent DF, et al. Inactivation of TGFbeta receptors in stem cells drives cutaneous squamous cell carcinoma. Nat Commun. 2016;7:12493.","journal-title":"Nat Commun"},{"issue":"12","key":"9_CR24","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1158\/1055-9965.1996.13.12","volume":"13","author":"PM Carpenter","year":"2004","unstructured":"Carpenter PM, Linden KG, McLaren CE, et al. Nuclear morphometry and molecular biomarkers of actinic keratosis, sun-damaged, and nonexposed skin. Cancer Epidemiol Biomark Prev. 2004;13(12):1996\u20132002.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"1","key":"9_CR25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/jamadermatol.2015.2705","volume":"152","author":"ALS Chang","year":"2016","unstructured":"Chang ALS, Kim J, Luciano R, et al. A case report of Unresectable Cutaneous Squamous Cell Carcinoma responsive to Pembrolizumab, a programmed cell death protein 1 inhibitor. JAMA Dermatol. 2016;152(1):106\u20138.","journal-title":"JAMA Dermatol"},{"issue":"2","key":"9_CR26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/1346-8138.13058","volume":"43","author":"P-S Cheng","year":"2016","unstructured":"Cheng P-S, Weng S-F, Chiang C-H, et al. Relationship between arsenic-containing drinking water and skin cancers in the arseniasis endemic areas in Taiwan. J Dermatol. 2016;43(2):181\u20136.","journal-title":"J Dermatol"},{"issue":"1 Pt 2","key":"9_CR27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1067\/mjd.2000.103344","volume":"42","author":"CJ Cockerell","year":"2000","unstructured":"Cockerell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma (\u201cactinic keratosis\u201d). J Am Acad Dermatol. 2000;42(1 Pt 2):11\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"9_CR28","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1001\/archderm.137.9.1162","volume":"137","author":"R Corona","year":"2001","unstructured":"Corona R, Dogliotti E, D'Errico M, et al. Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life. Arch Dermatol. 2001;137(9):1162\u20138.","journal-title":"Arch Dermatol"},{"issue":"11","key":"9_CR29","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/cncr.24284","volume":"115","author":"VD Criscione","year":"2009","unstructured":"Criscione VD, Weinstock MA, Naylor MF, et al. Actinic keratoses: natural history and risk of malignant transformation in the Veterans affairs topical Tretinoin Chemoprevention trial. Cancer. 2009;115(11):2523\u201330.","journal-title":"Cancer"},{"issue":"6923","key":"9_CR30","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nature01283","volume":"421","author":"M Dajee","year":"2003","unstructured":"Dajee M, Lazarov M, Zhang JY, et al. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature. 2003;421(6923):639\u201343.","journal-title":"Nature"},{"issue":"1","key":"9_CR31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/CJI.0000000000000146","volume":"40","author":"F Day","year":"2017","unstructured":"Day F, Kumar M, Fenton L, et al. Durable response of Metastatic Squamous Cell Carcinoma of the skin to Ipilimumab immunotherapy. J Immunother. 2017;40(1):36\u20138.","journal-title":"J Immunother"},{"issue":"2","key":"9_CR32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.canlet.2004.10.003","volume":"225","author":"L Daya-Grosjean","year":"2005","unstructured":"Daya-Grosjean L, Couve-Privat S. Sonic hedgehog signaling in basal cell carcinomas. Cancer Lett. 2005;225(2):181\u201392.","journal-title":"Cancer Lett"},{"issue":"1\u20132","key":"9_CR33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mrfmmm.2004.11.013","volume":"571","author":"L Daya-Grosjean","year":"2005","unstructured":"Daya-Grosjean L, Sarasin A. The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors. Mutat Res. 2005;571(1\u20132):43\u201356.","journal-title":"Mutat Res"},{"issue":"2","key":"9_CR34","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/bjd.12988","volume":"171","author":"S Deady","year":"2014","unstructured":"Deady S, Sharp L, Comber H. Increasing skin cancer incidence in young, affluent, urban populations: a challenge for prevention. Br J Dermatol. 2014;171(2):324\u201331.","journal-title":"Br J Dermatol"},{"issue":"4","key":"9_CR35","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/BF03187330","volume":"6","author":"NC Demirkan","year":"2000","unstructured":"Demirkan NC, Colakoglu N, Duzcan E. Value of p53 protein in biological behavior of basal cell carcinoma and in normal epithelia adjacent to carcinomas. Pathol Oncol Res. 2000;6(4):272\u20134.","journal-title":"Pathol Oncol Res"},{"issue":"34","key":"9_CR36","doi-asserted-by":"crossref","first-page":"35922","DOI":"10.18632\/oncotarget.5771","volume":"6","author":"E Denisova","year":"2015","unstructured":"Denisova E, Heidenreich B, Nagore E, et al. Frequent DPH3 promoter mutations in skin cancers. Oncotarget. 2015;6(34):35922\u201330.","journal-title":"Oncotarget"},{"issue":"12","key":"9_CR37","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nrc1229","volume":"3","author":"MM Di Pasca","year":"2003","unstructured":"Di Pasca MM, Hebrok M. Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer. 2003;3(12):903\u201311.","journal-title":"Nat Rev Cancer"},{"issue":"Suppl 61","key":"9_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2133.146.s61.2.x","volume":"146","author":"TL Diepgen","year":"2002","unstructured":"Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol. 2002;146(Suppl 61):1\u20136.","journal-title":"Br J Dermatol"},{"key":"9_CR39","volume-title":"Klinikleitfaden Dermatologie","author":"T Dirschka","year":"2011","unstructured":"Dirschka T, Hartwig R, Oster-Schmidt C. Klinikleitfaden Dermatologie. 3rd ed. M\u00fcnchen: Urban & Fischer Verlag\/Elsevier GmbH; 2011.","edition":"3"},{"issue":"6","key":"9_CR40","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0190-9622(84)80334-5","volume":"10","author":"H von Domarus","year":"1984","unstructured":"von Domarus H, Stevens PJ. Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol. 1984;10(6):1043\u201360.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"9_CR41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaad.2016.02.1226","volume":"75","author":"R Dummer","year":"2016","unstructured":"Dummer R, Guminski A, Gutzmer R, et al. The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 treatment (BOLT): a phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma. J Am Acad Dermatol. 2016;75(1):113\u2013125.e5.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"9_CR42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1158\/2159-8290.CD-11-0028","volume":"1","author":"S Durinck","year":"2011","unstructured":"Durinck S, Ho C, Wang NJ, et al. Temporal dissection of tumorigenesis in primary cancers. Cancer Discov. 2011;1(2):137\u201343.","journal-title":"Cancer Discov"},{"issue":"11","key":"9_CR43","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/jid.2010.169","volume":"130","author":"P Dziunycz","year":"2010","unstructured":"Dziunycz P, Iotzova-Weiss G, Eloranta JJ, et al. Squamous cell carcinoma of the skin shows a distinct microRNA profile modulated by UV radiation. J Invest Dermatol. 2010;130(11):2686\u20139.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"9_CR44","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1046\/j.1365-2133.2003.05240.x","volume":"148","author":"M El-Bahrawy","year":"2003","unstructured":"El-Bahrawy M, El-Masry N, Alison M, et al. Expression of beta-catenin in basal cell carcinoma. Br J Dermatol. 2003;148(5):964\u201370.","journal-title":"Br J Dermatol"},{"issue":"4","key":"9_CR45","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s00105-011-2128-7","volume":"62","author":"B Emmert","year":"2011","unstructured":"Emmert B, Hallier E, Sch\u00f6n MP, et al. Disease management guidelines in dermatology: implementation, potentials and limitations exemplified by the guidelines for the management of hand eczema. Hautarzt. 2011;62(4):308\u201314.","journal-title":"Hautarzt"},{"key":"9_CR46","doi-asserted-by":"crossref","unstructured":"Emmert S. Xeroderma pigmentosum, cockayne syndrome, trichothiodystrophy \u2013 defects in DNA repair and carcinogenesis. In: Hereditary tumors, pp. 421\u2013439.","DOI":"10.1002\/9783527627523.ch25"},{"key":"9_CR47","volume-title":"Xeroderma pigmentosum, Cockayne syndrome, and Trichothiodystrophy","author":"S Emmert","year":"2011","unstructured":"Emmert S. Xeroderma pigmentosum, Cockayne syndrome, and Trichothiodystrophy. Oxford: Wiley-Blackwell; 2011."},{"issue":"2","key":"9_CR48","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1751-1097.1995.tb03951.x","volume":"61","author":"S Emmert","year":"1995","unstructured":"Emmert S, Epe B, Saha-Moller CR, et al. Assessment of genotoxicity and mutagenicity of 1,2-dioxetanes in human cells using a plasmid shuttle vector. Photochem Photobiol. 1995;61(2):136\u201341.","journal-title":"Photochem Photobiol"},{"issue":"5","key":"9_CR49","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1073\/pnas.040559697","volume":"97","author":"S Emmert","year":"2000","unstructured":"Emmert S, Kobayashi N, Khan SG, et al. The xeroderma pigmentosum group C gene leads to selective repair of cyclobutane pyrimidine dimers rather than 6-4 photoproducts. Proc Natl Acad Sci USA. 2000;97(5):2151\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"9_CR50","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1610-0387.2006.06047.x","volume":"4","author":"S Emmert","year":"2006","unstructured":"Emmert S, Leibeling D, Runger TM. Syndromes with genetic instability: model diseases for (skin) cancerogenesis. J Dtsch Dermatol Ges. 2006;4(9):721\u201331.","journal-title":"J Dtsch Dermatol Ges"},{"key":"9_CR51","first-page":"6","volume":"5","author":"S Emmert","year":"2011","unstructured":"Emmert S, Sch\u00f6n MP. Biologika bei onkologischen Erkrankungen: Monoklonale Antik\u00f6rper in der Dermato-Onkologie. Med Rev. 2011;5:6\u20137.","journal-title":"Med Rev"},{"issue":"1","key":"9_CR52","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jaad.2009.12.042","volume":"65","author":"C Engelhardt","year":"2011","unstructured":"Engelhardt C, Curiel-Lewandrowski C, Warneke J, et al. Metastatic cutaneous squamous cell carcinoma responding to erlotinib therapy. J Am Acad Dermatol. 2011;65(1):237\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"9_CR53","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrc2503","volume":"8","author":"EH Epstein","year":"2008","unstructured":"Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer. 2008;8(10):743\u201354.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"9_CR54","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","volume":"152A","author":"DG Evans","year":"2010","unstructured":"Evans DG, Howard E, Giblin C, et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A. 2010;152A(2):327\u201332.","journal-title":"Am J Med Genet A"},{"issue":"5","key":"9_CR55","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","volume":"61","author":"ER Fearon","year":"1990","unstructured":"Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759\u201367.","journal-title":"Cell"},{"issue":"8","key":"9_CR56","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1038\/jid.2010.40","volume":"130","author":"LF Fecker","year":"2010","unstructured":"Fecker LF, Stockfleth E, Braun FK, et al. Enhanced death ligand-induced apoptosis in cutaneous SCC cells by treatment with diclofenac\/hyaluronic acid correlates with downregulation of c-FLIP. J Invest Dermatol. 2010;130(8):2098\u2013109.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"9_CR57","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/jid.2012.431","volume":"133","author":"SC Flohil","year":"2013","unstructured":"Flohil SC, Seubring I, van Rossum MM, et al. Trends in basal cell carcinoma incidence rates: a 37-year Dutch observational study. J Invest Dermatol. 2013;133(4):913\u20138.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"9_CR58","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2133.2006.07603.x","volume":"156","author":"GB Fogarty","year":"2007","unstructured":"Fogarty GB, Conus NM, Chu J, et al. Characterization of the expression and activation of the epidermal growth factor receptor in squamous cell carcinoma of the skin. Br J Dermatol. 2007;156(1):92\u20138.","journal-title":"Br J Dermatol"},{"issue":"10","key":"9_CR59","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/annonc\/mdu368","volume":"25","author":"MC Foote","year":"2014","unstructured":"Foote MC, McGrath M, Guminski A, et al. Phase II study of single-agent panitumumab in patients with incurable cutaneous squamous cell carcinoma. Ann Oncol. 2014;25(10):2047\u201352.","journal-title":"Ann Oncol"},{"key":"9_CR60","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-21771-9","volume-title":"Dermatologie und Venerologie","author":"P Fritsch","year":"1998","unstructured":"Fritsch P. Dermatologie und Venerologie. 1st ed. Berlin Heidelberg\/Berlin-Heidelberg: Springer-Verlag; 1998.","edition":"1"},{"issue":"1","key":"9_CR61","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ng0996-78","volume":"14","author":"MR Gailani","year":"1996","unstructured":"Gailani MR, Stahle-Backdahl M, Leffell DJ, et al. The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet. 1996;14(1):78\u201381.","journal-title":"Nat Genet"},{"issue":"6","key":"9_CR62","first-page":"419","volume":"5","author":"RP Gallagher","year":"1996","unstructured":"Gallagher RP, Bajdik CD, Fincham S, et al. Chemical exposures, medical history, and risk of squamous and basal cell carcinoma of the skin. Cancer Epidemiol Biomark Prev. 1996;5(6):419\u201324.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"2","key":"9_CR63","first-page":"157","volume":"131","author":"RP Gallagher","year":"1995","unstructured":"Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I Basal cell carcinoma Arch Dermatol. 1995;131(2):157\u201363.","journal-title":"I Basal cell carcinoma Arch Dermatol"},{"key":"9_CR64","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0065-3527(08)60834-9","volume":"37","author":"DA Galloway","year":"1989","unstructured":"Galloway DA, McDougall JK. Human papillomaviruses and carcinomas. Adv Virus Res. 1989;37:125\u201371.","journal-title":"Adv Virus Res"},{"key":"9_CR65","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/978-3-642-60622-9_4","volume-title":"Dermatologische Onkologie","author":"C Garbe","year":"1997","unstructured":"Garbe C. Epidemiologie des Hautkrebses. In: Dermatologische Onkologie. Berlin, Heidelberg: Springer; 1997. p. 40\u201356."},{"issue":"3","key":"9_CR66","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/humu.10179","volume":"21","author":"G Giglia-Mari","year":"2003","unstructured":"Giglia-Mari G, Sarasin A. TP53 mutations in human skin cancers. Hum Mutat. 2003;21(3):217\u201328.","journal-title":"Hum Mutat"},{"issue":"1 Pt 2","key":"9_CR67","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mjd.2000.103339","volume":"42","author":"RG Glogau","year":"2000","unstructured":"Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol. 2000;42(1 Pt 2):23\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"9_CR68","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1524-4725.1996.tb00312.x","volume":"22","author":"HM Gloster","year":"1996","unstructured":"Gloster HM, Brodland DG. The epidemiology of skin cancer. Dermatol Surg. 1996;22(3):217\u201326.","journal-title":"Dermatol Surg"},{"issue":"10","key":"9_CR69","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1610-0387.2010.07526.x","volume":"8","author":"D G\u00f6ppner","year":"2010","unstructured":"G\u00f6ppner D, Nekwasil S, Franke I, et al. Successful combination therapy of a locally advanced squamous cell carcinoma of the skin with cetuximab and gamma-irradiation. J Dtsch Dermatol Ges. 2010;8(10):826\u20138.","journal-title":"J Dtsch Dermatol Ges"},{"key":"9_CR70","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJM196005052621803","volume":"262","author":"RJ Gorlin","year":"1960","unstructured":"Gorlin RJ, GOLTZ RW. Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome. N Engl J Med. 1960;262:908\u201312.","journal-title":"N Engl J Med"},{"issue":"11","key":"9_CR71","doi-asserted-by":"crossref","first-page":"e80354","DOI":"10.1371\/journal.pone.0080354","volume":"8","author":"KG Griewank","year":"2013","unstructured":"Griewank KG, Murali R, Schilling B, et al. TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma. PLoS One. 2013;8(11):e80354.","journal-title":"PLoS One"},{"issue":"10","key":"9_CR72","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/archderm.1997.03890460087010","volume":"133","author":"D Grossman","year":"1997","unstructured":"Grossman D, Leffell DJ. The molecular basis of nonmelanoma skin cancer: new understanding. Arch Dermatol. 1997;133(10):1263\u201370.","journal-title":"Arch Dermatol"},{"issue":"1\u20133","key":"9_CR73","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1011-1344(01)00199-3","volume":"63","author":"FR de Gruijl","year":"2001","unstructured":"de Gruijl FR, van Kranen HJ, Mullenders LH. UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer. J Photochem Photobiol B. 2001;63(1\u20133):19\u201327.","journal-title":"J Photochem Photobiol B"},{"issue":"5","key":"9_CR74","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/120347540500900501","volume":"9","author":"AK Gupta","year":"2005","unstructured":"Gupta AK, Davey V, Mcphail H. Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: critical review and meta-analysis of efficacy studies. J Cutan Med Surg. 2005;9(5):209\u201314.","journal-title":"J Cutan Med Surg"},{"issue":"6","key":"9_CR75","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0092-8674(00)81268-4","volume":"85","author":"H Hahn","year":"1996","unstructured":"Hahn H, Wicking C, Zaphiropoulous PG, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell. 1996;85(6):841\u201351.","journal-title":"Cell"},{"issue":"1","key":"9_CR76","first-page":"203","volume":"8","author":"PA Hall","year":"1993","unstructured":"Hall PA, McKee PH, Menage HD, et al. High levels of p53 protein in UV-irradiated normal human skin. Oncogene. 1993;8(1):203\u20137.","journal-title":"Oncogene"},{"issue":"7","key":"9_CR77","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.ejca.2012.11.023","volume":"49","author":"K Harrington","year":"2013","unstructured":"Harrington K, Berrier A, Robinson M, et al. Randomised phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease. Eur J Cancer. 2013;49(7):1609\u201318.","journal-title":"Eur J Cancer"},{"issue":"1","key":"9_CR78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2340\/00015555-2181","volume":"96","author":"CA Harwood","year":"2016","unstructured":"Harwood CA, Proby CM, Inman GJ, et al. The promise of genomics and the development of targeted therapies for Cutaneous Squamous Cell Carcinoma. Acta Derm Venereol. 2016;96(1):3\u201316.","journal-title":"Acta Derm Venereol"},{"key":"9_CR79","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejca.2017.02.026","volume":"77","author":"A Hauschild","year":"2017","unstructured":"Hauschild A, Eichstaedt J, Mobus L, et al. Regression of melanoma metastases and multiple non-melanoma skin cancers in xeroderma pigmentosum by the PD1-antibody pembrolizumab. Eur J Cancer. 2017;77:84\u20137.","journal-title":"Eur J Cancer"},{"issue":"5","key":"9_CR80","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.ijrobp.2012.09.030","volume":"85","author":"CH Heath","year":"2013","unstructured":"Heath CH, Deep NL, Nabell L, et al. Phase 1 study of erlotinib plus radiation therapy in patients with advanced cutaneous squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2013;85(5):1275\u201381.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"9_CR81","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1200\/JCO.2001.19.1.231","volume":"19","author":"SA de Hertog","year":"2001","unstructured":"de Hertog SA, Wensveen CA, Bastiaens MT, et al. Relation between smoking and skin cancer. J Clin Oncol. 2001;19(1):231\u20138.","journal-title":"J Clin Oncol"},{"issue":"6835","key":"9_CR82","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/35077232","volume":"411","author":"JH Hoeijmakers","year":"2001","unstructured":"Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature. 2001;411(6835):366\u201374.","journal-title":"Nature"},{"issue":"6","key":"9_CR83","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1600-0625.2010.01086.x","volume":"19","author":"GFL Hofbauer","year":"2010","unstructured":"Hofbauer GFL, Bouwes Bavinck JN, Euvrard S. Organ transplantation and skin cancer: basic problems and new perspectives. Exp Dermatol. 2010;19(6):473\u201382.","journal-title":"Exp Dermatol"},{"issue":"6719","key":"9_CR84","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/17401","volume":"397","author":"M Hojo","year":"1999","unstructured":"Hojo M, Morimoto T, Maluccio M, et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature. 1999;397(6719):530\u20134.","journal-title":"Nature"},{"issue":"5015","key":"9_CR85","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1905840","volume":"253","author":"M Hollstein","year":"1991","unstructured":"Hollstein M, Sidransky D, Vogelstein B, et al. p53 mutations in human cancers. Science. 1991;253(5015):49\u201353.","journal-title":"Science"},{"issue":"1","key":"9_CR86","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archderm.1959.01560130069008","volume":"79","author":"JB Howell","year":"1959","unstructured":"Howell JB, CARO MR. The basal-cell nevus: its relationship to multiple cutaneous cancers and associated anomalies of development. AMA Arch Derm. 1959;79(1):67\u201377.. discussion 77-80","journal-title":"AMA Arch Derm"},{"issue":"3","key":"9_CR87","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cell.2010.06.040","volume":"142","author":"M Huarte","year":"2010","unstructured":"Huarte M, Guttman M, Feldser D, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell. 2010;142(3):409\u201319.","journal-title":"Cell"},{"issue":"3","key":"9_CR88","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.0303-6987.2005.00281.x","volume":"32","author":"MR Hussein","year":"2005","unstructured":"Hussein MR. Ultraviolet radiation and skin cancer: molecular mechanisms. J Cutan Pathol. 2005;32(3):191\u2013205.","journal-title":"J Cutan Pathol"},{"issue":"2","key":"9_CR89","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1101\/gad.1258705","volume":"19","author":"ME Hutchin","year":"2005","unstructured":"Hutchin ME, Kariapper MST, Grachtchouk M, et al. Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle. Genes Dev. 2005;19(2):214\u201323.","journal-title":"Genes Dev"},{"issue":"7","key":"9_CR90","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1158\/2159-8290.CD-13-0239","volume":"3","author":"R Iglesias-Bartolome","year":"2013","unstructured":"Iglesias-Bartolome R, Martin D, Gutkind JS. Exploiting the head and neck cancer oncogenome: widespread PI3K-mTOR pathway alterations and novel molecular targets. Cancer Discov. 2013;3(7):722\u20135.","journal-title":"Cancer Discov"},{"issue":"1","key":"9_CR91","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/s41467-018-06027-1","volume":"9","author":"GJ Inman","year":"2018","unstructured":"Inman GJ, Wang J, Nagano A, et al. The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature. Nat Commun. 2018;9(1):3667.","journal-title":"Nat Commun"},{"issue":"5","key":"9_CR92","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1016\/j.jaad.2010.06.054","volume":"66","author":"JK Iwasaki","year":"2012","unstructured":"Iwasaki JK, Srivastava D, Moy RL, et al. The molecular genetics underlying basal cell carcinoma pathogenesis and links to targeted therapeutics. J Am Acad Dermatol. 2012;66(5):e167\u201378.","journal-title":"J Am Acad Dermatol"},{"key":"9_CR93","first-page":"232","volume":"4","author":"A Jacob","year":"1827","unstructured":"Jacob A. Observations respecting an ulcer of peculiar character, which attacks the eyelids and other parts of the face. Hospital Rep Commun Med Surg. 1827;4:232\u20139.","journal-title":"Hospital Rep Commun Med Surg"},{"issue":"3","key":"9_CR94","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/1097-0142(19820201)49:3<533::AID-CNCR2820490322>3.0.CO;2-O","volume":"49","author":"GH Jacobs","year":"1982","unstructured":"Jacobs GH, Rippey JJ, Altini M. Prediction of aggressive behavior in basal cell carcinoma. Cancer. 1982;49(3):533\u20137.","journal-title":"Cancer"},{"key":"9_CR95","first-page":"162","volume":"28","author":"W Jarisch","year":"1894","unstructured":"Jarisch W. Zur Lehre von den Hautgeschwulsten. Arch Dermatol Syphilol (Berl). 1894;28:162\u2013222.","journal-title":"Arch Dermatol Syphilol (Berl)"},{"issue":"1","key":"9_CR96","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/jid.2013.276","volume":"134","author":"SS Jayaraman","year":"2014","unstructured":"Jayaraman SS, Rayhan DJ, Hazany S, et al. Mutational landscape of basal cell carcinomas by whole-exome sequencing. J Invest Dermatol. 2014;134(1):213\u201320.","journal-title":"J Invest Dermatol"},{"key":"9_CR97","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pdpdt.2016.04.017","volume":"17","author":"W Jerjes","year":"2017","unstructured":"Jerjes W, Hamdoon Z, Abdulkareem AA, et al. Photodynamic therapy in the management of actinic keratosis: retrospective evaluation of outcome. Photodiagn Photodyn Ther. 2017;17:200\u20134.","journal-title":"Photodiagn Photodyn Ther"},{"issue":"29","key":"9_CR98","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1038\/sj.onc.1202789","volume":"18","author":"W Jiang","year":"1999","unstructured":"Jiang W, Ananthaswamy HN, Muller HK, et al. p53 protects against skin cancer induction by UV-B radiation. Oncogene. 1999;18(29):4247\u201353.","journal-title":"Oncogene"},{"issue":"5268","key":"9_CR99","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.272.5268.1668","volume":"272","author":"RL Johnson","year":"1996","unstructured":"Johnson RL, Rothman AL, Xie J, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science. 1996;272(5268):1668\u201371.","journal-title":"Science"},{"issue":"3","key":"9_CR100","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0190-9622(00)90209-3","volume":"42","author":"K Kalka","year":"2000","unstructured":"Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J Am Acad Dermatol. 2000;42(3):389\u2013413.. quiz 414-6","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"9_CR101","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1172\/JCI58779","volume":"122","author":"M Kasper","year":"2012","unstructured":"Kasper M, Jaks V, Hohl D, et al. Basal cell carcinoma - molecular biology and potential new therapies. J Clin Invest. 2012;122(2):455\u201363.","journal-title":"J Clin Invest"},{"issue":"1","key":"9_CR102","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng1279","volume":"36","author":"H Katayama","year":"2004","unstructured":"Katayama H, Sasai K, Kawai H, et al. Phosphorylation by aurora kinase a induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet. 2004;36(1):55\u201362.","journal-title":"Nat Genet"},{"issue":"6","key":"9_CR103","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1046\/j.1523-1747.2002.01769.x","volume":"118","author":"KA Katz","year":"2002","unstructured":"Katz KA, Marcil I, Stern RS. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients. J Invest Dermatol. 2002;118(6):1038\u201343.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"9_CR104","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.1711070107","volume":"107","author":"JF Kerr","year":"1972","unstructured":"Kerr JF, Searle J. A suggested explanation for the paradoxically slow growth rate of basal-cell carcinomas that contain numerous mitotic figures. J Pathol. 1972;107(1):41\u20134.","journal-title":"J Pathol"},{"issue":"4","key":"9_CR105","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrc1838","volume":"6","author":"PA Khavari","year":"2006","unstructured":"Khavari PA. Modelling cancer in human skin tissue. Nat Rev Cancer. 2006;6(4):270\u201380.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"9_CR106","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/aje\/kwq427","volume":"173","author":"ML Kile","year":"2011","unstructured":"Kile ML, Hoffman E, Rodrigues EG, et al. A pathway-based analysis of urinary arsenic metabolites and skin lesions. Am J Epidemiol. 2011;173(7):778\u201386.","journal-title":"Am J Epidemiol"},{"issue":"8","key":"9_CR107","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1200\/JCO.2013.49.9525","volume":"32","author":"DJ Kim","year":"2014","unstructured":"Kim DJ, Kim J, Spaunhurst K, et al. Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma. J Clin Oncol. 2014;32(8):745\u201351.","journal-title":"J Clin Oncol"},{"issue":"3","key":"9_CR108","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1158\/1078-0432.CCR-14-1756","volume":"21","author":"HS Kim","year":"2015","unstructured":"Kim HS, Kwon HJ, Jung I, et al. Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and\/or metastatic squamous cell carcinoma of head and neck. Clin Cancer Res. 2015;21(3):544\u201352.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"9_CR109","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ccr.2010.02.027","volume":"17","author":"J Kim","year":"2010","unstructured":"Kim J, Tang JY, Gong R, et al. Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth. Cancer Cell. 2010;17(4):388\u201399.","journal-title":"Cancer Cell"},{"issue":"1","key":"9_CR110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0923-1811(01)00170-0","volume":"29","author":"M-Y Kim","year":"2002","unstructured":"Kim M-Y, Park HJ, Baek S-C, et al. Mutations of the p53 and PTCH gene in basal cell carcinomas: UV mutation signature and strand bias. J Dermatol Sci. 2002;29(1):1\u20139.","journal-title":"J Dermatol Sci"},{"issue":"8","key":"9_CR111","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/ncb1750","volume":"10","author":"V Kolev","year":"2008","unstructured":"Kolev V, Mandinova A, Guinea-Viniegra J, et al. EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer. Nat Cell Biol. 2008;10(8):902\u201311.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"9_CR112","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/carcin\/5.4.511","volume":"5","author":"KH Kraemer","year":"1984","unstructured":"Kraemer KH, Lee MM, Scotto J. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum. Carcinogenesis. 1984;5(4):511\u20134.","journal-title":"Carcinogenesis"},{"issue":"4","key":"9_CR113","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/1523-1747.ep12373002","volume":"102","author":"Y Kubo","year":"1994","unstructured":"Kubo Y, Urano Y, Yoshimoto K, et al. p53 gene mutations in human skin cancers and precancerous lesions: comparison with immunohistochemical analysis. J Invest Dermatol. 1994;102(4):440\u20134.","journal-title":"J Invest Dermatol"},{"issue":"10","key":"9_CR114","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1600-0625.2011.01320.x","volume":"20","author":"C Kuschal","year":"2011","unstructured":"Kuschal C, Thoms K-M, Boeckmann L, et al. Cyclosporin a inhibits nucleotide excision repair via downregulation of the xeroderma pigmentosum group a and G proteins, which is mediated by calcineurin inhibition. Exp Dermatol. 2011;20(10):795\u20139.","journal-title":"Exp Dermatol"},{"issue":"1","key":"9_CR115","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1600-0625.2011.01413.x","volume":"21","author":"C Kuschal","year":"2012","unstructured":"Kuschal C, Thoms K-M, Schubert S, et al. Skin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repair. Exp Dermatol. 2012;21(1):2\u20136.","journal-title":"Exp Dermatol"},{"issue":"2","key":"9_CR116","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/bjc.2013.760","volume":"110","author":"SR Lambert","year":"2014","unstructured":"Lambert SR, Mladkova N, Gulati A, et al. Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling. Br J Cancer. 2014;110(2):520\u20139.","journal-title":"Br J Cancer"},{"issue":"17","key":"9_CR117","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1038\/emboj.2009.172","volume":"28","author":"PM Lansdorp","year":"2009","unstructured":"Lansdorp PM. Telomeres and disease. EMBO J. 2009;28(17):2532\u201340.","journal-title":"EMBO J"},{"issue":"10","key":"9_CR118","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/nm779","volume":"8","author":"M Lazarov","year":"2002","unstructured":"Lazarov M, Kubo Y, Cai T, et al. CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis. Nat Med. 2002;8(10):1105\u201314.","journal-title":"Nat Med"},{"issue":"5","key":"9_CR119","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1046\/j.1523-1747.2001.t01-1-15292.x","volume":"117","author":"F Le Pelletier","year":"2001","unstructured":"Le Pelletier F, Soufir N, de La Salmoniere P, et al. p53 patches are not increased in patients with multiple nonmelanoma skin cancers. J Invest Dermatol. 2001;117(5):1324\u20135.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"9_CR120","first-page":"744","volume":"37","author":"KG Leblanc","year":"2011","unstructured":"Leblanc KG, Hughes MP, Sheehan DJ. The role of sirolimus in the prevention of cutaneous squamous cell carcinoma in organ transplant recipients. Dermatol Surg. 2011;37(6):744\u20139.","journal-title":"Dermatol Surg"},{"issue":"11","key":"9_CR121","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1111170","volume":"366","author":"M Lebwohl","year":"2012","unstructured":"Lebwohl M, Swanson N, Anderson LL, et al. Ingenol mebutate gel for actinic keratosis. N Engl J Med. 2012;366(11):1010\u20139.","journal-title":"N Engl J Med"},{"issue":"10","key":"9_CR122","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/ng.3091","volume":"46","author":"CS Lee","year":"2014","unstructured":"Lee CS, Bhaduri A, Mah A, et al. Recurrent point mutations in the kinetochore gene KNSTRN in cutaneous squamous cell carcinoma. Nat Genet. 2014;46(10):1060\u20132.","journal-title":"Nat Genet"},{"issue":"11","key":"9_CR123","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1001\/archderm.1991.01680100063005","volume":"127","author":"DJ Leffell","year":"1991","unstructured":"Leffell DJ, Headington JT, Wong DS, et al. Aggressive-growth basal cell carcinoma in young adults. Arch Dermatol. 1991;127(11):1663\u20137.","journal-title":"Arch Dermatol"},{"issue":"5\u20137","key":"9_CR124","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10735-006-9041-x","volume":"37","author":"D Leibeling","year":"2006","unstructured":"Leibeling D, Laspe P, Emmert S. Nucleotide excision repair and cancer. J Mol Histol. 2006;37(5\u20137):225\u201338.","journal-title":"J Mol Histol"},{"issue":"27","key":"9_CR125","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1038\/onc.2013.323","volume":"33","author":"C Leufke","year":"2014","unstructured":"Leufke C, Leykauf J, Krunic D, et al. The telomere profile distinguishes two classes of genetically distinct cutaneous squamous cell carcinomas. Oncogene. 2014;33(27):3506\u201318.","journal-title":"Oncogene"},{"issue":"5","key":"9_CR126","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1158\/1078-0432.CCR-11-1951","volume":"18","author":"CM Lewis","year":"2012","unstructured":"Lewis CM, Glisson BS, Feng L, et al. A phase II study of gefitinib for aggressive cutaneous squamous cell carcinoma of the head and neck. Clin Cancer Res. 2012;18(5):1435\u201346.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"9_CR127","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1158\/1078-0432.CCR-14-1773","volume":"21","author":"YY Li","year":"2015","unstructured":"Li YY, Hanna GJ, Laga AC, et al. Genomic analysis of metastatic cutaneous squamous cell carcinoma. Clin Cancer Res. 2015;21(6):1447\u201356.","journal-title":"Clin Cancer Res"},{"key":"9_CR128","doi-asserted-by":"crossref","unstructured":"Lipson E J, Bagnasco S M, Moore J Jr et al (2016) Tumor regression and allograft rejection after administration of anti-PD-1. N Engl J Med 374(9): 896\u2013898.","DOI":"10.1056\/NEJMc1509268"},{"issue":"5 Pt 1","key":"9_CR129","first-page":"715","volume":"24","author":"JS Lo","year":"1991","unstructured":"Lo JS, Snow SN, Reizner GT, et al. Metastatic basal cell carcinoma: report of twelve cases with a review of the literature. J Am Acad Dermatol. 1991;24(5 Pt 1):715\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"9_CR130","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","volume":"3","author":"DB Longley","year":"2003","unstructured":"Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3(5):330\u20138.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"9_CR131","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1158\/1078-0432.CCR-10-2745","volume":"17","author":"PM LoRusso","year":"2011","unstructured":"LoRusso PM, Rudin CM, Reddy JC, et al. Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors. Clin Cancer Res. 2011;17(8):2502\u201311.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"9_CR132","first-page":"819","volume":"26","author":"Y Lou","year":"2010","unstructured":"Lou Y, Yang X, Wang F, et al. MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein. Int J Mol Med. 2010;26(6):819\u201327.","journal-title":"Int J Mol Med"},{"issue":"7","key":"9_CR133","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1158\/2159-8290.CD-13-0103","volume":"3","author":"VWY Lui","year":"2013","unstructured":"Lui VWY, Hedberg ML, Li H, et al. Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. Cancer Discov. 2013;3(7):761\u20139.","journal-title":"Cancer Discov"},{"issue":"5678","key":"9_CR134","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1126\/science.1098020","volume":"304","author":"L Lum","year":"2004","unstructured":"Lum L, Beachy PA. The hedgehog response network: sensors, switches, and routers. Science. 2004;304(5678):1755\u20139.","journal-title":"Science"},{"issue":"3","key":"9_CR135","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0022-3476(99)70456-7","volume":"134","author":"O Makitie","year":"1999","unstructured":"Makitie O, Pukkala E, Teppo L, et al. Increased incidence of cancer in patients with cartilage-hair hypoplasia. J Pediatr. 1999;134(3):315\u20138.","journal-title":"J Pediatr"},{"issue":"2 Suppl","key":"9_CR136","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/1097-0142(19950115)75:2+<607::AID-CNCR2820751402>3.0.CO;2-8","volume":"75","author":"R Marks","year":"1995","unstructured":"Marks R. An overview of skin cancers. Incidence and causation. Cancer. 1995;75(2 Suppl):607\u201312.","journal-title":"Cancer"},{"issue":"8589","key":"9_CR137","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(88)91658-3","volume":"1","author":"R Marks","year":"1988","unstructured":"Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet. 1988;1(8589):795\u20137.","journal-title":"Lancet"},{"issue":"6237","key":"9_CR138","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.aaa6806","volume":"348","author":"I Martincorena","year":"2015","unstructured":"Martincorena I, Roshan A, Gerstung M, et al. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science. 2015;348(6237):880\u20136.","journal-title":"Science"},{"issue":"25","key":"9_CR139","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1200\/JCO.2010.34.1735","volume":"29","author":"E Maubec","year":"2011","unstructured":"Maubec E, Petrow P, Scheer-Senyarich I, et al. Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin. J Clin Oncol. 2011;29(25):3419\u201326.","journal-title":"J Clin Oncol"},{"issue":"6","key":"9_CR140","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2340\/0001555561497503","volume":"61","author":"G Michaelsson","year":"1981","unstructured":"Michaelsson G, Olsson E, Westermark P. The Rombo syndrome: a familial disorder with vermiculate atrophoderma, milia, hypotrichosis, trichoepitheliomas, basal cell carcinomas and peripheral vasodilation with cyanosis. Acta Derm Venereol. 1981;61(6):497\u2013503.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"9_CR141","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1805131","volume":"379","author":"MR Migden","year":"2018","unstructured":"Migden MR, Rischin D, Schmults CD, et al. PD-1 blockade with Cemiplimab in advanced cutaneous squamous-cell carcinoma. N Engl J Med. 2018;379(4):341\u201351.","journal-title":"N Engl J Med"},{"issue":"10","key":"9_CR142","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1053\/jlts.2002.35551","volume":"8","author":"AB Mithoefer","year":"2002","unstructured":"Mithoefer AB, Supran S, Freeman RB. Risk factors associated with the development of skin cancer after liver transplantation. Liver Transpl. 2002;8(10):939\u201344.","journal-title":"Liver Transpl"},{"issue":"9","key":"9_CR143","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1365-4362.1998.00467.x","volume":"37","author":"MA Mittelbronn","year":"1998","unstructured":"Mittelbronn MA, Mullins DL, Ramos-Caro FA, et al. Frequency of pre-existing actinic keratosis in cutaneous squamous cell carcinoma. Int J Dermatol. 1998;37(9):677\u201381.","journal-title":"Int J Dermatol"},{"issue":"5","key":"9_CR144","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1158\/1535-7163.MCT-08-0592","volume":"8","author":"T Moriyama","year":"2009","unstructured":"Moriyama T, Ohuchida K, Mizumoto K, et al. MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol Cancer Ther. 2009;8(5):1067\u201374.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"9_CR145","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1365-2133.2003.04898.x","volume":"148","author":"H Nakaseko","year":"2003","unstructured":"Nakaseko H, Kobayashi M, Akita Y, et al. Histological changes and involvement of apoptosis after photodynamic therapy for actinic keratoses. Br J Dermatol. 2003;148(1):122\u20137.","journal-title":"Br J Dermatol"},{"issue":"1","key":"9_CR146","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1073\/pnas.91.1.360","volume":"91","author":"H Nakazawa","year":"1994","unstructured":"Nakazawa H, English D, Randell PL, et al. UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. Proc Natl Acad Sci USA. 1994;91(1):360\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"9_CR147","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3390\/ijerph15071442","volume":"15","author":"FK Noubissi","year":"2018","unstructured":"Noubissi FK, Yedjou CG, Spiegelman VS, et al. Cross-talk between Wnt and Hh signaling pathways in the pathology of basal cell carcinoma. Int J Environ Res Public Health. 2018;15(7):1442.","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"9_CR148","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.cell.2015.01.043","volume":"160","author":"N Oshimori","year":"2015","unstructured":"Oshimori N, Oristian D, Fuchs E. TGF-beta promotes heterogeneity and drug resistance in squamous cell carcinoma. Cell. 2015;160(5):963\u201376.","journal-title":"Cell"},{"issue":"1","key":"9_CR149","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2133.2011.10334.x","volume":"165","author":"LJMT Parren","year":"2011","unstructured":"Parren LJMT, Frank J. Hereditary tumour syndromes featuring basal cell carcinomas. Br J Dermatol. 2011;165(1):30\u20134.","journal-title":"Br J Dermatol"},{"issue":"11","key":"9_CR150","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.3390\/ijms18112485","volume":"18","author":"C Pellegrini","year":"2017","unstructured":"Pellegrini C, Maturo MG, Di Nardo L, et al. Understanding the molecular genetics of basal cell carcinoma. Int J Mol Sci. 2017;18(11):2485.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"9_CR151","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1158\/2159-8290.CD-12-0537","volume":"3","author":"CR Pickering","year":"2013","unstructured":"Pickering CR, Zhang J, Yoo SY, et al. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov. 2013;3(7):770\u201381.","journal-title":"Cancer Discov"},{"issue":"3","key":"9_CR152","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/mc.2940040306","volume":"4","author":"WE Pierceall","year":"1991","unstructured":"Pierceall WE, Goldberg LH, Tainsky MA, et al. Ras gene mutation and amplification in human nonmelanoma skin cancers. Mol Carcinog. 1991;4(3):196\u2013202.","journal-title":"Mol Carcinog"},{"issue":"5","key":"9_CR153","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00403-005-0601-9","volume":"297","author":"D Pirard","year":"2005","unstructured":"Pirard D, Vereecken P, Melot C, et al. Three percent diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses: a meta-analysis of the recent studies. Arch Dermatol Res. 2005;297(5):185\u20139.","journal-title":"Arch Dermatol Res"},{"issue":"8","key":"9_CR154","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1038\/jid.2014.163","volume":"134","author":"H Populo","year":"2014","unstructured":"Populo H, Boaventura P, Vinagre J, et al. TERT promoter mutations in skin cancer: the effects of sun exposure and X-irradiation. J Invest Dermatol. 2014;134(8):2251\u20137.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"9_CR155","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/jid.2008.408","volume":"129","author":"KJ Purdie","year":"2009","unstructured":"Purdie KJ, Harwood CA, Gulati A, et al. Single nucleotide polymorphism array analysis defines a specific genetic fingerprint for well-differentiated cutaneous SCCs. J Invest Dermatol. 2009;129(6):1562\u20138.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"9_CR156","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/gcc.2870110404","volume":"11","author":"AG Quinn","year":"1994","unstructured":"Quinn AG, Sikkink S, Rees JL. Delineation of two distinct deleted regions on chromosome 9 in human non-melanoma skin cancers. Genes Chromosomes Cancer. 1994;11(4):222\u20135.","journal-title":"Genes Chromosomes Cancer"},{"issue":"12","key":"9_CR157","first-page":"2483","volume":"12","author":"I Rehman","year":"1996","unstructured":"Rehman I, Takata M, Wu YY, et al. Genetic change in actinic keratoses. Oncogene. 1996;12(12):2483\u201390.","journal-title":"Oncogene"},{"issue":"1","key":"9_CR158","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2133.2005.06353.x","volume":"152","author":"J Reifenberger","year":"2005","unstructured":"Reifenberger J, Wolter M, Knobbe CB, et al. Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol. 2005;152(1):43\u201351.","journal-title":"Br J Dermatol"},{"issue":"2","key":"9_CR159","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/CCO.0000000000000359","volume":"29","author":"S Ribero","year":"2017","unstructured":"Ribero S, Stucci LS, Daniels GA, et al. Drug therapy of advanced cutaneous squamous cell carcinoma: is there any evidence? Curr Opin Oncol. 2017;29(2):129\u201335.","journal-title":"Curr Opin Oncol"},{"issue":"12","key":"9_CR160","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/nm.2265","volume":"16","author":"TW Ridky","year":"2010","unstructured":"Ridky TW, Chow JM, Wong DJ, et al. Invasive three-dimensional organotypic neoplasia from multiple normal human epithelia. Nat Med. 2010;16(12):1450\u20135.","journal-title":"Nat Med"},{"issue":"5","key":"9_CR161","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1365-2559.1998.00431.x","volume":"32","author":"JJ Rippey","year":"1998","unstructured":"Rippey JJ. Why classify basal cell carcinomas? Histopathology. 1998;32(5):393\u20138.","journal-title":"Histopathology"},{"key":"9_CR162","unstructured":"Robert Koch-Institut. Bericht zum Krebsgeschehen in Deutschland 2016."},{"issue":"Pt 2","key":"9_CR163","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1242\/jcs.110.2.113","volume":"110","author":"U Rodeck","year":"1997","unstructured":"Rodeck U, Jost M, Kari C, et al. EGF-R dependent regulation of keratinocyte survival. J Cell Sci. 1997;110(Pt 2):113\u201321.","journal-title":"J Cell Sci"},{"issue":"10","key":"9_CR164","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","volume":"151","author":"HW Rogers","year":"2015","unstructured":"Rogers HW, Weinstock MA, Feldman SR, et al. Incidence estimate of onmelanoma skin cancer (Keratinocyte Carcinomas) in the U.S. population, 2012. JAMA Dermatol. 2015;151(10):1081\u20136.","journal-title":"JAMA Dermatol"},{"issue":"9","key":"9_CR165","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/ncb435","volume":"9","author":"R Rohatgi","year":"2007","unstructured":"Rohatgi R, Scott MP. Patching the gaps in Hedgehog signalling. Nat Cell Biol. 2007;9(9):1005\u20139.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"9_CR166","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaad.2010.12.038","volume":"66","author":"RH Rosen","year":"2012","unstructured":"Rosen RH, Gupta AK, Tyring SK. Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response. J Am Acad Dermatol. 2012;66(3):486\u201393.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"9_CR167","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1751-1097.1999.tb08285.x","volume":"70","author":"BS Rosenstein","year":"1999","unstructured":"Rosenstein BS, Phelps RG, Weinstock MA, et al. p53 mutations in basal cell carcinomas arising in routine users of sunscreens. Photochem Photobiol. 1999;70(5):798\u2013806.","journal-title":"Photochem Photobiol"},{"issue":"9","key":"9_CR168","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1038\/jid.2008.165","volume":"128","author":"TM Runger","year":"2008","unstructured":"Runger TM. C\u2013T transition mutations are not solely UVB-signature mutations, because they are also generated by UVA. J Invest Dermatol. 2008;128(9):2138\u201340.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"9_CR169","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1039\/C1PP05232B","volume":"11","author":"TM Runger","year":"2012","unstructured":"Runger TM, Farahvash B, Hatvani Z, et al. Comparison of DNA damage responses following equimutagenic doses of UVA and UVB: a less effective cell cycle arrest with UVA may render UVA-induced pyrimidine dimers more mutagenic than UVB-induced ones. Photochem Photobiol Sci. 2012;11(1):207\u201315.","journal-title":"Photochem Photobiol Sci"},{"issue":"1 Pt 2","key":"9_CR170","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1067\/mjd.2000.103342","volume":"42","author":"SJ Salasche","year":"2000","unstructured":"Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42(1 Pt 2):4\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"2 Pt 1","key":"9_CR171","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0190-9622(97)70287-1","volume":"36","author":"CA Sander","year":"1997","unstructured":"Sander CA, Pfeiffer C, Kligman AM, et al. Chemotherapy for disseminated actinic keratoses with 5-fluorouracil and isotretinoin. J Am Acad Dermatol. 1997;36(2 Pt 1):236\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"9_CR172","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00403-012-1243-3","volume":"304","author":"A Sch\u00e4fer","year":"2012","unstructured":"Sch\u00e4fer A, Emmert S, Kruppa J, et al. No association of vitamin D metabolism-related polymorphisms and melanoma risk as well as melanoma prognosis: a case-control study. Arch Dermatol Res. 2012;304(5):353\u201361.","journal-title":"Arch Dermatol Res"},{"issue":"15","key":"9_CR173","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/djg016","volume":"95","author":"M Sch\u00f6n","year":"2003","unstructured":"Sch\u00f6n M, Bong AB, Drewniok C, et al. Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod. J Natl Cancer Inst. 2003;95(15):1138\u201349.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"9_CR174","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/gene.2009.40","volume":"10","author":"N Schoof","year":"2009","unstructured":"Schoof N, von Bonin F, Konig IR, et al. Distal and proximal interleukin (IL)-10 promoter polymorphisms associated with risk of cutaneous melanoma development: a case\u2013\u2013control study. Genes Immun. 2009;10(6):586\u201390.","journal-title":"Genes Immun"},{"issue":"4","key":"9_CR175","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/modpathol.2013.167","volume":"27","author":"GA Scott","year":"2014","unstructured":"Scott GA, Laughlin TS, Rothberg PG. Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma. Mod Pathol. 2014;27(4):516\u201323.","journal-title":"Mod Pathol"},{"issue":"1","key":"9_CR176","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s12885-017-3286-5","volume":"17","author":"A Sekulic","year":"2017","unstructured":"Sekulic A, Migden MR, Basset-Seguin N, et al. Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study. BMC Cancer. 2017;17(1):332.","journal-title":"BMC Cancer"},{"issue":"23","key":"9_CR177","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1113713","volume":"366","author":"A Sekulic","year":"2012","unstructured":"Sekulic A, Migden MR, Oro AE, et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med. 2012;366(23):2171\u20139.","journal-title":"N Engl J Med"},{"issue":"6 Pt 1","key":"9_CR178","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/0190-9622(90)70344-H","volume":"23","author":"M Sexton","year":"1990","unstructured":"Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol. 1990;23(6 Pt 1):1118\u201326.","journal-title":"J Am Acad Dermatol"},{"issue":"16","key":"9_CR179","doi-asserted-by":"crossref","first-page":"733","DOI":"10.5694\/j.1326-5377.1966.tb97484.x","volume":"2","author":"H Silverstone","year":"1966","unstructured":"Silverstone H, Gordon D. Regional studies in skin cancer. 2. Wet tropical and subtropical coasts of Queensland. Med J Aust. 1966;2(16):733\u201340.","journal-title":"Med J Aust"},{"issue":"45","key":"9_CR180","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1038\/sj.onc.1203130","volume":"18","author":"RV Sionov","year":"1999","unstructured":"Sionov RV, Haupt Y. The cellular response to p53: the decision between life and death. Oncogene. 1999;18(45):6145\u201357.","journal-title":"Oncogene"},{"issue":"8","key":"9_CR181","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/jid.2011.48","volume":"131","author":"H Skvara","year":"2011","unstructured":"Skvara H, Kalthoff F, Meingassner JG, et al. Topical treatment of basal cell carcinomas in nevoid basal cell carcinoma syndrome with a smoothened inhibitor. J Invest Dermatol. 2011;131(8):1735\u201344.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"9_CR182","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/hmg\/8.2.291","volume":"8","author":"I Smyth","year":"1999","unstructured":"Smyth I, Narang MA, Evans T, et al. Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome 1p32. Hum Mol Genet. 1999;8(2):291\u20137.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"9_CR183","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.semcdb.2012.01.017","volume":"23","author":"AP South","year":"2012","unstructured":"South AP, Cho RJ, Aster JC. The double-edged sword of Notch signaling in cancer. Semin Cell Dev Biol. 2012;23(4):458\u201364.","journal-title":"Semin Cell Dev Biol"},{"issue":"10","key":"9_CR184","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1038\/jid.2014.154","volume":"134","author":"AP South","year":"2014","unstructured":"South AP, Purdie KJ, Watt SA, et al. NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis. J Invest Dermatol. 2014;134(10):2630\u20138.","journal-title":"J Invest Dermatol"},{"issue":"6046","key":"9_CR185","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1208130","volume":"333","author":"N Stransky","year":"2011","unstructured":"Stransky N, Egloff AM, Tward AD, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011;333(6046):1157\u201360.","journal-title":"Science"},{"issue":"14","key":"9_CR186","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.ejca.2015.06.110","volume":"51","author":"A Stratigos","year":"2015","unstructured":"Stratigos A, Garbe C, Lebbe C, et al. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur J Cancer. 2015;51(14):1989\u20132007.","journal-title":"Eur J Cancer"},{"issue":"2","key":"9_CR187","first-page":"96","volume":"14","author":"S Tabs","year":"2004","unstructured":"Tabs S, Avci O. Induction of the differentiation and apoptosis of tumor cells in vivo with efficiency and selectivity. Eur J Dermatol. 2004;14(2):96\u2013102.","journal-title":"Eur J Dermatol"},{"issue":"12","key":"9_CR188","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3923\/pjbs.2009.929.933","volume":"12","author":"S Talghini","year":"2009","unstructured":"Talghini S, Halimi M, Baybordi H. Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease. Pak J Biol Sci. 2009;12(12):929\u201333.","journal-title":"Pak J Biol Sci"},{"issue":"8 Pt 1","key":"9_CR189","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1288\/00005537-199508000-00008","volume":"105","author":"E Tavin","year":"1995","unstructured":"Tavin E, Persky MS, Jacobs J. Metastatic basal cell carcinoma of the head and neck. Laryngoscope. 1995;105(8 Pt 1):814\u20137.","journal-title":"Laryngoscope"},{"key":"9_CR190","first-page":"173","volume":"4","author":"MA Tejani","year":"2010","unstructured":"Tejani MA, Cohen RB, Mehra R. The contribution of cetuximab in the treatment of recurrent and\/or metastatic head and neck cancer. Biologics. 2010;4:173\u201385.","journal-title":"Biologics"},{"key":"9_CR191","volume-title":"Histological typing of skin tumours","author":"T Seldam","year":"1974","unstructured":"Seldam T, Jan RE, Helwig EB. Histological typing of skin tumours. Geneva: World Health Organization; 1974."},{"issue":"6","key":"9_CR192","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1080\/00365510701230481","volume":"67","author":"KM Thoms","year":"2007","unstructured":"Thoms KM, Baesecke J, Emmert B, et al. Functional DNA repair system analysis in haematopoietic progenitor cells using host cell reactivation. Scand J Clin Lab Invest. 2007;67(6):580\u20138.","journal-title":"Scand J Clin Lab Invest"},{"issue":"6","key":"9_CR193","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1600-0625.2007.00559.x","volume":"16","author":"K-M Thoms","year":"2007","unstructured":"Thoms K-M, Kuschal C, Emmert S. Lessons learned from DNA repair defective syndromes. Exp Dermatol. 2007;16(6):532\u201344.","journal-title":"Exp Dermatol"},{"issue":"3","key":"9_CR194","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1600-0625.2010.01213.x","volume":"20","author":"K-M Thoms","year":"2011","unstructured":"Thoms K-M, Kuschal C, Oetjen E, et al. Cyclosporin A, but not everolimus, inhibits DNA repair mediated by calcineurin: implications for tumorigenesis under immunosuppression. Exp Dermatol. 2011;20(3):232\u20136.","journal-title":"Exp Dermatol"},{"issue":"6","key":"9_CR195","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/j.1365-2133.2005.06587.x","volume":"152","author":"CMLJ Tilli","year":"2005","unstructured":"Tilli CMLJ, Van Steensel MAM, Krekels GAM, et al. Molecular aetiology and pathogenesis of basal cell carcinoma. Br J Dermatol. 2005;152(6):1108\u201324.","journal-title":"Br J Dermatol"},{"key":"9_CR196","doi-asserted-by":"crossref","unstructured":"Trodello C, Pepper J-P, Wong M et al. Cisplatin and cetuximab treatment for metastatic cutaneous squamous cell carcinoma: a systematic review, United States, 2017 Jan.","DOI":"10.1097\/DSS.0000000000000799"},{"issue":"1","key":"9_CR197","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ajmg.c.30037","volume":"131C","author":"KY Tsai","year":"2004","unstructured":"Tsai KY, Tsao H. The genetics of skin cancer. Am J Med Genet C Semin Med Genet. 2004;131C(1):82\u201392.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"4","key":"9_CR198","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0022-5347(01)67517-7","volume":"153","author":"T Uchida","year":"1995","unstructured":"Uchida T, Wada C, Ishida H, et al. p53 mutations and prognosis in bladder tumors. J Urol. 1995;153(4):1097\u2013104.","journal-title":"J Urol"},{"issue":"11","key":"9_CR199","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1158\/1535-7163.MCT-11-0422","volume":"10","author":"A Uhmann","year":"2011","unstructured":"Uhmann A, Niemann H, Lammering B, et al. Antitumoral effects of calcitriol in basal cell carcinomas involve inhibition of hedgehog signaling and induction of vitamin D receptor signaling and differentiation. Mol Cancer Ther. 2011;10(11):2179\u201388.","journal-title":"Mol Cancer Ther"},{"key":"9_CR200","doi-asserted-by":"crossref","first-page":"357040","DOI":"10.1155\/2012\/357040","volume":"2012","author":"A Uhmann","year":"2012","unstructured":"Uhmann A, Niemann H, Lammering B, et al. Calcitriol inhibits hedgehog signaling and induces vitamin d receptor signaling and differentiation in the patched mouse model of embryonal rhabdomyosarcoma. Sarcoma. 2012;2012:357040.","journal-title":"Sarcoma"},{"issue":"6","key":"9_CR201","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.prp.2011.03.002","volume":"207","author":"P Uribe","year":"2011","unstructured":"Uribe P, Gonzalez S. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy. Pathol Res Pract. 2011;207(6):337\u201342.","journal-title":"Pathol Res Pract"},{"issue":"6","key":"9_CR202","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ajmg.1320450628","volume":"45","author":"P Vabres","year":"1993","unstructured":"Vabres P, de Prost Y. Bazex-Dupre-Christol syndrome: a possible diagnosis for basal cell carcinomas, coarse sparse hair, and milia. Am J Med Genet. 1993;45(6):786.","journal-title":"Am J Med Genet"},{"issue":"4","key":"9_CR203","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/1523-1747.ep12874504","volume":"94","author":"JG van der Schroeff","year":"1990","unstructured":"van der Schroeff JG, Evers LM, Boot AJ, et al. Ras oncogene mutations in basal cell carcinomas and squamous cell carcinomas of human skin. J Invest Dermatol. 1990;94(4):423\u20135.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"9_CR204","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1524-4725.1978.tb00375.x","volume":"4","author":"TR Wade","year":"1978","unstructured":"Wade TR, Ackerman AB. The many faces of basal-cell carcinoma. J Dermatol Surg Oncol. 1978;4(1):23\u20138.","journal-title":"J Dermatol Surg Oncol"},{"issue":"1","key":"9_CR205","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ccr.2010.11.007","volume":"19","author":"GY Wang","year":"2011","unstructured":"Wang GY, Wang J, Mancianti M-L, et al. Basal cell carcinomas arise from hair follicle stem cells in Ptch1(+\/\u2212) mice. Cancer Cell. 2011;19(1):114\u201324.","journal-title":"Cancer Cell"},{"issue":"43","key":"9_CR206","doi-asserted-by":"crossref","first-page":"17761","DOI":"10.1073\/pnas.1114669108","volume":"108","author":"NJ Wang","year":"2011","unstructured":"Wang NJ, Sanborn Z, Arnett KL, et al. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc Natl Acad Sci USA. 2011;108(43):17761\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"9_CR207","doi-asserted-by":"crossref","first-page":"6279","DOI":"10.1073\/pnas.0812401106","volume":"106","author":"Y Wang","year":"2009","unstructured":"Wang Y, DiGiovanna JJ, Stern JB, et al. Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas. Proc Natl Acad Sci USA. 2009;106(15):6279\u201384.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"9_CR208","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/bjc.1996.113","volume":"73","author":"AJ Waring","year":"1996","unstructured":"Waring AJ, Takata M, Rehman I, et al. Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma. Br J Cancer. 1996;73(5):649\u201353.","journal-title":"Br J Cancer"},{"issue":"6","key":"9_CR209","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archderm.1995.01690180077014","volume":"131","author":"MA Weinstock","year":"1995","unstructured":"Weinstock MA, Coulter S, Bates J, et al. Human papillomavirus and widespread cutaneous carcinoma after PUVA photochemotherapy. Arch Dermatol. 1995;131(6):701\u20134.","journal-title":"Arch Dermatol"},{"key":"9_CR210","first-page":"477","volume":"12","author":"JC White","year":"1894","unstructured":"White JC. Multiple benign cystic epitheliomas. J Cutan Genitourin Dis. 1894;12:477\u201384.","journal-title":"J Cutan Genitourin Dis"},{"issue":"2","key":"9_CR211","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/bjd.14664","volume":"176","author":"JK Winkler","year":"2017","unstructured":"Winkler JK, Schneiderbauer R, Bender C, et al. Anti-programmed cell death-1 therapy in nonmelanoma skin cancer. Br J Dermatol. 2017;176(2):498\u2013502.","journal-title":"Br J Dermatol"},{"issue":"4","key":"9_CR212","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1610-0387.2009.07268_supp.x","volume":"8","author":"G Wozel","year":"2010","unstructured":"Wozel G, Sticherling M, Schon MP. Cutaneous side effects of inhibition of VEGF signal transduction. J Dtsch Dermatol Ges. 2010;8(4):243\u20139.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"9_CR213","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/abbs\/gmx127","volume":"50","author":"F Wu","year":"2018","unstructured":"Wu F, Weigel KJ, Zhou H, et al. Paradoxical roles of TGF-beta signaling in suppressing and promoting squamous cell carcinoma. Acta Biochim Biophys Sin Shanghai. 2018;50(1):98\u2013105.","journal-title":"Acta Biochim Biophys Sin Shanghai"},{"issue":"7296","key":"9_CR214","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature08996","volume":"465","author":"X Wu","year":"2010","unstructured":"Wu X, Nguyen B-C, Dziunycz P, et al. Opposing roles for calcineurin and ATF3 in squamous skin cancer. Nature. 2010;465(7296):368\u201372.","journal-title":"Nature"},{"issue":"6662","key":"9_CR215","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/34201","volume":"391","author":"J Xie","year":"1998","unstructured":"Xie J, Murone M, Luoh SM, et al. Activating smoothened mutations in sporadic basal-cell carcinoma. Nature. 1998;391(6662):90\u20132.","journal-title":"Nature"},{"issue":"5","key":"9_CR216","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/mc.20716","volume":"50","author":"V Yadav","year":"2011","unstructured":"Yadav V, Denning MF. Fyn is induced by Ras\/PI3K\/Akt signaling and is required for enhanced invasion\/migration. Mol Carcinog. 2011;50(5):346\u201352.","journal-title":"Mol Carcinog"},{"issue":"9","key":"9_CR217","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/ng.192","volume":"40","author":"SH Yang","year":"2008","unstructured":"Yang SH, Andl T, Grachtchouk V, et al. Pathological responses to oncogenic hedgehog signaling in skin are dependent on canonical Wnt\/beta3-catenin signaling. Nat Genet. 2008;40(9):1130\u20135.","journal-title":"Nat Genet"},{"issue":"5952","key":"9_CR218","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.1179386","volume":"326","author":"RL Yauch","year":"2009","unstructured":"Yauch RL, Dijkgraaf GJP, Alicke B, et al. Smoothened mutation confers resistance to a hedgehog pathway inhibitor in medulloblastoma. Science. 2009;326(5952):572\u20134.","journal-title":"Science"},{"issue":"4","key":"9_CR219","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","volume":"163","author":"F-X Yu","year":"2015","unstructured":"Yu F-X, Zhao B, Guan K-L. Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell. 2015;163(4):811\u201328.","journal-title":"Cell"},{"issue":"4","key":"9_CR220","first-page":"787","volume":"59","author":"PG Zaphiropoulos","year":"1999","unstructured":"Zaphiropoulos PG, Unden AB, Rahnama F, et al. PTCH2, a novel human patched gene, undergoing alternative splicing and up-regulated in basal cell carcinomas. Cancer Res. 1999;59(4):787\u201392.","journal-title":"Cancer Res"},{"issue":"2","key":"9_CR221","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0002-9440(10)63980-6","volume":"158","author":"H Zhang","year":"2001","unstructured":"Zhang H, Ping XL, Lee PK, et al. Role of PTCH and p53 genes in early-onset basal cell carcinoma. Am J Pathol. 2001;158(2):381\u20135.","journal-title":"Am J Pathol"},{"issue":"3","key":"9_CR222","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.stem.2011.01.014","volume":"8","author":"L Zhang","year":"2011","unstructured":"Zhang L, Stokes N, Polak L, et al. Specific microRNAs are preferentially expressed by skin stem cells to balance self-renewal and early lineage commitment. Cell Stem Cell. 2011;8(3):294\u2013308.","journal-title":"Cell Stem Cell"},{"issue":"24","key":"9_CR223","doi-asserted-by":"crossref","first-page":"9439","DOI":"10.1158\/0008-5472.CAN-09-2976","volume":"69","author":"L Zhao","year":"2009","unstructured":"Zhao L, Li W, Marshall C, et al. Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53. Cancer Res. 2009;69(24):9439\u201347.","journal-title":"Cancer Res"},{"issue":"9","key":"9_CR224","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1073\/pnas.90.9.4216","volume":"90","author":"A Ziegler","year":"1993","unstructured":"Ziegler A, Leffell DJ, Kunala S, et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA. 1993;90(9):4216\u201320.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Advances in Experimental Medicine and Biology","Sunlight, Vitamin D and Skin Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-46227-7_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T06:54:21Z","timestamp":1696661661000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-46227-7_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030462260","9783030462277"],"references-count":224,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-46227-7_9","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"12 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}